Koers Medovex Corp Nasdaq
Aandelen
US58504H1014
Geavanceerde medische apparatuur & technologie
Omzet 2021 | 1,61 mln. 1,48 mln. | Omzet 2022 | 453K 416K | Marktkapitalisatie | 1,62 mln. 1,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -4 mln. -3,67 mln. | Nettowinst (verlies) 2022 | -10 mln. -9,17 mln. | EV/omzet 2021 | 7,95 x |
Nettoschuld 2021 | 3,52 mln. 3,23 mln. | Nettoschuld 2022 | 3,92 mln. 3,6 mln. | EV/omzet 2022 | 12,2 x |
K/w-verhouding 2021 |
-1,73
x | K/w-verhouding 2022 |
-0,08
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 35,62% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 08-01-19 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 04-02-19 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 15-06-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 65 | 17-01-22 | |
Chief Executive Officer | 53 | 08-01-19 | |
Chairman | 77 | 08-01-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,64% | 208 mld. | |
+8,99% | 182 mld. | |
+29,83% | 155 mld. | |
+35,17% | 115 mld. | |
+2,55% | 66,52 mld. | |
+15,06% | 53,93 mld. | |
-6,47% | 46,26 mld. | |
-2,14% | 38,22 mld. | |
+6,88% | 36,6 mld. |